Lei Li1, Jing Li1, Benjamin M Drum1, Yi Chen1, Haifeng Yin1, Xiaoyun Guo1, Stephen W Luckey2, Merle L Gilbert3, G Stanley McKnight3, John D Scott3,4, L Fernando Santana5, Qinghang Liu6. 1. Department of Physiology and Biophysics, University of Washington, 1705 NE Pacific Street, Seattle, WA 98195, USA. 2. Department of Biology, Seattle University, 901 12th Ave., Seattle, WA 98122, USA. 3. Department of Pharmacology, University of Washington, 1705 NE Pacific Street, Seattle, WA 98195, USA. 4. Howard Hughes Medical Institute, University of Washington, 1705 NE Pacific Street, Seattle, WA 98195, USA. 5. Deparment of Physiology & Membrane Biology, University of California, One Shields Ave., Davis, CA 95616, USA. 6. Department of Physiology and Biophysics, University of Washington, 1705 NE Pacific Street, Seattle, WA 98195, USA; qcliu@u.washington.edu.
Abstract
AIMS: Impaired Ca2 + cycling and myocyte contractility are a hallmark of heart failure triggered by pathological stress such as hemodynamic overload. The A-Kinase anchoring protein AKAP150 has been shown to coordinate key aspects of adrenergic regulation of Ca2+ cycling and excitation-contraction in cardiomyocytes. However, the role of the AKAP150 signalling complexes in the pathogenesis of heart failure has not been investigated. METHODS AND RESULTS: Here we examined how AKAP150 signalling complexes impact Ca2+ cycling, myocyte contractility, and heart failure susceptibility following pathological stress. We detected a significant reduction of AKAP150 expression in the failing mouse heart induced by pressure overload. Importantly, cardiac-specific AKAP150 knockout mice were predisposed to develop dilated cardiomyopathy with severe cardiac dysfunction and fibrosis after pressure overload. Loss of AKAP150 also promoted pathological remodelling and heart failure progression following myocardial infarction. However, ablation of AKAP150 did not affect calcineurin-nuclear factor of activated T cells signalling in cardiomyocytes or pressure overload- or agonist-induced cardiac hypertrophy. Immunoprecipitation studies showed that AKAP150 was associated with SERCA2, phospholamban, and ryanodine receptor-2, providing a targeted control of sarcoplasmic reticulum Ca2+ regulatory proteins. Mechanistically, loss of AKAP150 led to impaired Ca2+ cycling and reduced myocyte contractility reserve following adrenergic stimulation or pressure overload. CONCLUSIONS: These findings define a critical role for AKAP150 in regulating Ca2+ cycling and myocardial ionotropy following pathological stress, suggesting the AKAP150 signalling pathway may serve as a novel therapeutic target for heart failure. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Impaired Ca2 + cycling and myocyte contractility are a hallmark of heart failure triggered by pathological stress such as hemodynamic overload. The A-Kinase anchoring protein AKAP150 has been shown to coordinate key aspects of adrenergic regulation of Ca2+ cycling and excitation-contraction in cardiomyocytes. However, the role of the AKAP150 signalling complexes in the pathogenesis of heart failure has not been investigated. METHODS AND RESULTS: Here we examined how AKAP150 signalling complexes impact Ca2+ cycling, myocyte contractility, and heart failure susceptibility following pathological stress. We detected a significant reduction of AKAP150 expression in the failing mouse heart induced by pressure overload. Importantly, cardiac-specific AKAP150 knockout mice were predisposed to develop dilated cardiomyopathy with severe cardiac dysfunction and fibrosis after pressure overload. Loss of AKAP150 also promoted pathological remodelling and heart failure progression following myocardial infarction. However, ablation of AKAP150 did not affect calcineurin-nuclear factor of activated T cells signalling in cardiomyocytes or pressure overload- or agonist-induced cardiac hypertrophy. Immunoprecipitation studies showed that AKAP150 was associated with SERCA2, phospholamban, and ryanodine receptor-2, providing a targeted control of sarcoplasmic reticulum Ca2+ regulatory proteins. Mechanistically, loss of AKAP150 led to impaired Ca2+ cycling and reduced myocyte contractility reserve following adrenergic stimulation or pressure overload. CONCLUSIONS: These findings define a critical role for AKAP150 in regulating Ca2+ cycling and myocardial ionotropy following pathological stress, suggesting the AKAP150 signalling pathway may serve as a novel therapeutic target for heart failure. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Catherine A Makarewich; Robert N Correll; Hui Gao; Hongyu Zhang; Baohua Yang; Remus M Berretta; Victor Rizzo; Jeffery D Molkentin; Steven R Houser Journal: Circ Res Date: 2012-02-02 Impact factor: 17.367
Authors: Genevieve C Pare; Andrea L Bauman; Molly McHenry; Jennifer J Carlisle Michel; Kimberly L Dodge-Kafka; Michael S Kapiloff Journal: J Cell Sci Date: 2005-12-01 Impact factor: 5.285
Authors: Michael D Kritzer; Jinliang Li; Catherine L Passariello; Marjorie Gayanilo; Hrishikesh Thakur; Joseph Dayan; Kimberly Dodge-Kafka; Michael S Kapiloff Journal: Circ Heart Fail Date: 2014-05-08 Impact factor: 8.790
Authors: Huiming Li; Matthew D Pink; Jonathan G Murphy; Alexander Stein; Mark L Dell'Acqua; Patrick G Hogan Journal: Nat Struct Mol Biol Date: 2012-02-19 Impact factor: 15.369
Authors: Thomas M D Sheard; Miriam E Hurley; John Colyer; Ed White; Ruth Norman; Eleftheria Pervolaraki; Kaarjel K Narayanasamy; Yufeng Hou; Hannah M Kirton; Zhaokang Yang; Liam Hunter; Jung-Uk Shim; Alexander H Clowsley; Andrew J Smith; David Baddeley; Christian Soeller; Michael A Colman; Izzy Jayasinghe Journal: ACS Nano Date: 2019-02-08 Impact factor: 15.881